Koninklijke DSM N.V (DSM.AS) Revenue Growth

Price: $114.05
Market Cap: $763.73M
Avg Volume: 343.13K
Country: NL
Industry: Chemicals - Specialty
Sector: Basic Materials
Beta: 0.71528
52W Range: $105.8-157.3
Website: Koninklijke DSM N.V

What is Koninklijke DSM N.V's Revenue Growth?

  • Koninklijke DSM N.V's annual revenue growth as of FY 2022 is -8.84%.
  • Koninklijke DSM N.V's quarterly revenue growth as of Q4 2022 is 0.00%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess Koninklijke DSM N.V's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $8.39B
    • Quarterly: $2.14B
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $5.70B
    • Quarterly: $1.51B
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: -5.63%
    • Quarterly Growth: 0.00%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $2.69B
    • Quarterly: $632.00M
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: -14.98%
    • Quarterly Growth: 0.00%

These metrics provide insights into Koninklijke DSM N.V's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

-8.84%

Quarterly Revenue Growth

0.00%

Historical Annual Revenue Growth
13.55%13.55%7.66%7.66%1.77%1.77%-4.12%-4.12%-10.00%-10.00%-15.89%-15.89%Revenue Growth (Annual)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Quarterly Revenue Growth
47.60%47.60%29.90%29.90%12.21%12.21%-5.49%-5.49%-23.19%-23.19%-40.88%-40.88%Revenue Growth (Quarterly)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023
Historical Annual Revenue
$10.00B$10.00B$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00Revenue (Annual)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Quarterly Revenue
$3.00B$3.00B$2.40B$2.40B$1.80B$1.80B$1.20B$1.20B$600.00M$600.00M$0.00$0.00Revenue (Quarterly)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Annual Cost of Revenue
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00Cost of Revenue (Annual)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Quarterly Cost of Revenue
$8.00B$8.00B$6.00B$6.00B$4.00B$4.00B$2.00B$2.00B$0.00$0.00Cost of Revenue (Quarterly)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Annual Gross Profit
$3.60B$3.60B$2.70B$2.70B$1.80B$1.80B$900.00M$900.00M$0.00$0.00Gross Profit (Annual)20142014201520152016201620172017201820182019201920202020202120212022202220232023
Historical Quarterly Gross Profit
$4.00B$4.00B$2.00B$2.00B$0.00$0.00-$2.00B-$2.00B-$4.00B-$4.00B-$6.00B-$6.00BGross Profit (Quarterly)20142014201520152016201620172017201820182019201920202020202120212022202220232023

Koninklijke DSM N.V Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2022 $8.39B -8.84% $5.70B -5.63% $2.69B -14.98%
2021 $9.20B 13.55% $6.04B 13.32% $3.16B 13.98%
2020 $8.11B -10.03% $5.33B -10.53% $2.78B -9.07%
2019 $9.01B -2.77% $5.96B 1.62% $3.05B -10.34%
2018 $9.27B 7.36% $5.86B 2.86% $3.40B 16.09%
2017 $8.63B 8.99% $5.70B 8.30% $2.93B 10.35%
2016 $7.92B 2.56% $5.26B -0.17% $2.66B 8.45%
2015 $7.72B -15.89% $5.27B -22.23% $2.45B 2.00%
2014 $9.18B 1.44% $6.78B 3.24% $2.40B -3.34%
2013 $9.05B -0.88% $6.57B -2.29% $2.49B 3.07%

Related Metrics

Explore detailed financial metrics and analysis for DSM.AS.